BioScrip, Inc. (BIOS) Tops Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts BIOS Hot Sheet
Join SI Premium – FREE
BioScrip, Inc. (NASDAQ: BIOS) reported Q3 EPS of $0.10, $0.01 better than the analyst estimate of $0.09. Revenue for the quarter came in at $454 million versus the consensus estimate of $444.73 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Construction Partners, Inc. (ROAD) Tops Q3 EPS by 1c ; Offers Guidance
- Douglas Elliman (DOUG) Reports Q2 Loss of $0.05
- Gyre Therapeutics (GYRE) Misses Q2 EPS by 6c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
